Ed Lavelle is an Immunologist, focusing on vaccine research. He was elected a member of the Royal Irish Academy (MRIA) in 2021, was President of The European Congress of Immunology 2024 and former President of the Irish Society for Immunology and head of the School of Biochemistry and Immunology at Trinity College Dublin, Ireland. He graduated with a BSc in Microbiology from University College Galway and a PhD in Immunology from the University of Plymouth and carried out postdoctoral research at the University of Nottingham and Trinity College Dublin on vaccine adjuvants and immunomodulation. He was appointed at Trinity College Dublin as a lecturer in 2004, associate Professor in 2012, Professor in Immunology in 2015 and Professor of Vaccine Immunology in 2022. His research has led to the identification of adjuvants suitable for inclusion in injectable and mucosal vaccines for infectious diseases and resolving their mode of action. The lab is also focused on developing therapeutic vaccines for cancer and investigating vaccine strategies that promote immunogenic cell death, leading to enhanced protective immunity.